HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents (2024)
- Authors:
- Waitman, Karoline de Barros
- Almeida, Larissa Costa de
- Primi, Marina Candido
- Carlos, Jorge Antonio Elias Godoy
- Ruiz, Claudia
- Kronenberger, Thales
- Laufer, Stefan
- Goettert, Marcia Ines
- Poso, Antti
- Vassiliades, Sandra Valeria
- Souza, Vinicius Albuquerque Moreira de
- Toledo, Mônica Franco Zannini Junqueira
- Hassimotto, Neuza Mariko Aymoto
- Cameron, Michael D
- Bannister, Thomas D
- Costa-Lotufo, Letícia Veras
- Machado Neto, João Agostinho
- Tavares, Maurício T.
- Parise Filho, Roberto
- Waitman, Karoline de Barros
- USP affiliated authors: TOLEDO, MONICA FRANCO ZANNINI JUNQUEIRA - FCF ; HASSIMOTTO, NEUZA MARIKO AYMOTO - FCF ; LOTUFO, LETICIA VERAS COSTA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; PARISE FILHO, ROBERTO - FCF ; WAITMAN, KAROLINE DE BARROS - FCF ; ALMEIDA, LARISSA COSTA DE - ICB ; CARLOS, JORGE ANTONIO ELIAS GODOY - ICB ; VASSILIADES, SANDRA VALERIA - FCF
- Unidades: FCF; ICB
- DOI: 10.1016/j.ejmech.2023.115935
- Subjects: ANTINEOPLÁSICOS; HIBRIDIZAÇÃO; CÉLULAS CULTIVADAS DE TUMOR; PROTEÍNAS; PURINAS; CITOTOXINAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Issy-Les-Moulineaux
- Date published: 2024
- Source:
- Título: European Journal of Medicinal Chemistry
- ISSN: 0223-5234
- Volume/Número/Paginação/Ano: v. 263, p. 1-18 art. 115935, 2024
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Acessar versão aberta:
-
ABNT
WAITMAN, Karoline de Barros et al. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, v. 263, p. 1-18 art. 115935, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ejmech.2023.115935. Acesso em: 31 mar. 2026. -
APA
Waitman, K. de B., Almeida, L. C. de, Primi, M. C., Carlos, J. A. E. G., Ruiz, C., Kronenberger, T., et al. (2024). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, 263, 1-18 art. 115935. doi:10.1016/j.ejmech.2023.115935 -
NLM
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Costa-Lotufo LV, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2026 mar. 31 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935 -
Vancouver
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Costa-Lotufo LV, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2026 mar. 31 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935 - Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models
- Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- Efficient synthesis of 6-Arylaminoflavones via buchwald-hartwig amination and its anti-tumor Investigation
- Synthesis of 6-arylaminoflavones via buchwald–hartwig amination and Its anti-tumor investigation
- Dona Flor and her two husbands: discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment
- Capsaicin-inspired hydroxamate hybrids as selective HDAC6 inhibitors with antiproliferative activity in hematological malignancies
- Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models
- Compostos híbridos e usos dos referidos compostos
- Synthesis and biological evaluation of purine-benzohydroxamates as potential inhibitors of PI3K and HDAC6 for the treatment of hematologic malignancies
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3165451.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
